These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24979671)

  • 41. Lung T-Cell Profile Alterations are Associated with Bronchiolitis Obliterans Syndrome in Cystic Fibrosis Lung Transplant Recipients.
    Hayes D; Harhay MO; Nicol KK; Liyanage NPM; Keller BC; Robinson RT
    Lung; 2020 Feb; 198(1):157-161. PubMed ID: 31807920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactivation of cytomegalovirus with acute rejection and cytomegalovirus infection with obliterative bronchiolitis in rat lung allografts.
    Yagyu K; van Breda Vriesman PJ; Duijvestijn AM; Bruggeman CA; Steinhoff G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1152-4. PubMed ID: 8382853
    [No Abstract]   [Full Text] [Related]  

  • 43. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation.
    Sato M; Hwang DM; Guan Z; Yeung JC; Anraku M; Wagnetz D; Hirayama S; Waddell TK; Liu M; Keshavjee S
    Am J Pathol; 2011 Sep; 179(3):1287-300. PubMed ID: 21763265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
    Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
    Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?
    Emtiazjoo AM; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):145-9. PubMed ID: 23087052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
    Hirt SW; von Suesskind-Schwendi M; Puehler T; Schmid C; Lehle K
    Transplant Proc; 2013 Mar; 45(2):783-6. PubMed ID: 23498820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling.
    Sato M; Keshavjee S
    Semin Thorac Cardiovasc Surg; 2008; 20(2):173-82. PubMed ID: 18707652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 54. Monitoring regulatory T cells as a prognostic marker in lung transplantation.
    Khan MA; Lau CL; Krupnick AS
    Front Immunol; 2023; 14():1235889. PubMed ID: 37818354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed development of obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials.
    Ross DJ; Jordan SC; Nathan SD; Kass RM; Koerner SK
    Chest; 1996 Apr; 109(4):870-3. PubMed ID: 8635362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Immune Response to Acute Gastric Fluid Aspiration in a Rat Model of Lung Transplantation.
    Chang JC; Finn SM; Davis RP; Sanders NL; Holzknecht ZE; Everett ML; Barbas AS; Parker W; Lin SS
    Exp Clin Transplant; 2019 Feb; 17(1):84-92. PubMed ID: 29697356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TNFα from classically activated macrophages accentuates epithelial to mesenchymal transition in obliterative bronchiolitis.
    Borthwick LA; Corris PA; Mahida R; Walker A; Gardner A; Suwara M; Johnson GE; Moisey EJ; Brodlie M; Ward C; Perry JD; De Soyza A; Mann DA; Fisher AJ
    Am J Transplant; 2013 Mar; 13(3):621-33. PubMed ID: 23331923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation.
    Sato M; Hirayama S; Hwang DM; Lara-Guerra H; Wagnetz D; Waddell TK; Liu M; Keshavjee S
    J Immunol; 2009 Jun; 182(11):7307-16. PubMed ID: 19454728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased donor-specific cytotoxic T cell precursor frequencies one year after clinical lung transplantation do not reflect transplantation tolerance: a comparison of lung transplant recipients with or without bronchiolitis obliterans syndrome.
    de Haan A; van der Gun I; Hepkema BG; de Boer WJ; van der Bij W; de Leij LF; Prop J
    Transplantation; 2000 Apr; 69(7):1434-9. PubMed ID: 10798767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction.
    Mikols CL; Yan L; Norris JY; Russell TD; Khalifah AP; Hachem RR; Chakinala MM; Yusen RD; Castro M; Kuo E; Patterson GA; Mohanakumar T; Trulock EP; Walter MJ
    Am J Respir Crit Care Med; 2006 Aug; 174(4):461-70. PubMed ID: 16728708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.